Research.Patient.info
Helicobacter pylori infection research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- Other
An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the pharmacokinetics of repeated doses of an approved antibiotic in healthy participants
This early-stage study looks at how a new stomach acid medicine, linaprazan glurate, affects a common antibiotic when given together. It helps us understand if these medicines work well and safely as a team in healthy people. This could be useful for conditions like stomach ulcers or reflux.
Sweden - authorisedTherapeutic confirmatory (Phase III)
A Randomized, Multicenter, Single-Blind, Parallel-Group Phase III Non-Inferiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Metronidazole, Bismuth Oxide and Tetracycline HCl to Standard Concomitant Non-Bismuth Quadruple Therapy for First-Line Eradication of Helicobacter pylori in Adults.
This study compares a new combination medicine to standard treatment for *Helicobacter pylori* infection, a common stomach bug. We want to see if the new medicine works just as well and is easy to take. Success is measured by getting rid of the infection.
Greece